跳至主要内容
临床试验/NCT05543382
NCT05543382终止不适用

Cycling Study With the Axonics System

Axonics, Inc.6 个研究点 分布在 1 个国家目标入组 31 人开始时间: 2022年8月9日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
Axonics, Inc.
入组人数
31
试验地点
6
主要终点
To evaluate the efficacy of daily cyclic stimulation of 2 hours "on" and 22 hours "off" in reducing UUI episodes by > 50% in newly implanted participants, or maintenance of efficacy in currently implanted participants with an implanted Axonics System

研究概览

简要总结

A prospective, multi-center, study comparing continuous sacral neuromodulation (SNM) stimulation to daily cyclic stimulation of 2 hours "on" and 22 hours "off" using the Axonics System.

详细描述

After consent is provided, the required visits are at Baseline, Day 0, 1-Month, and 3-Month. At the follow-up visits, a bladder diary is reviewed, symptoms are assessed, the PGI-I questionnaire is completed, and cyclic stimulation hours may be changed.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participants who are ≥ 21 years at the time of consent
  • Has a primary indication of UUI (participants with a secondary indication of UF or FI may also be enrolled)
  • Has a diagnosis of UUI for greater than or equal to 6 months prior to the date of consent
  • UUI episodes:
  • For currently implanted participants (Group A), they must be considered therapy responders with a >50% reduction in UUI episodes (based on their original baseline diaries) and satisfied with their SNM therapy
  • For de novo candidates (Group B), they must have completed a successful PNE documented with a >50% reduction in UUI episodes on a 3-day diary (a diary must exist within a medical record or equivalent)
  • Willing and capable of providing informed consent
  • Agrees to return to the site for all study visits
  • Fluent (able to speak and read) in English

排除标准

  • Any participant that the study Investigator deems to be a poor candidate who is unable to complete a 72-hour bladder diary or will be non-compliant for study visits
  • Diagnosis of urinary retention
  • Surgical treatment for stress incontinence (e.g. sling, Burch), and/or pelvic organ prolapse in the past 3 months or recommended or planned within 3 months from the time of consent
  • Changes to current regimen of medications that could impact bladder function within 4 weeks prior to consent
  • Current urinary tract mechanical obstruction (e.g., benign prostatic enlargement or urethral stricture)
  • Current symptomatic urinary tract infection (UTI)
  • A patient who early discontinued from the ARTISTRY registry
  • A female with a positive urine pregnancy test
  • A female who is breastfeeding

结局指标

主要结局

To evaluate the efficacy of daily cyclic stimulation of 2 hours "on" and 22 hours "off" in reducing UUI episodes by > 50% in newly implanted participants, or maintenance of efficacy in currently implanted participants with an implanted Axonics System

时间窗: 3 months

Comparison of UUI episodes on a 3-day bladder diary at 3 months as compared to baseline UUI episodes

次要结局

  • To evaluate patient satisfaction with cyclic stimulation(3 months)

研究者

发起方
Axonics, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验